These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16327259)

  • 1. Anticoagulation in ischemic stroke: opportunities in arterial disease.
    van Gijn J; Algra A
    Cerebrovasc Dis; 2005; 20 Suppl 2():101-8. PubMed ID: 16327259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.
    Ann Neurol; 1997 Dec; 42(6):857-65. PubMed ID: 9403477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of ESPRIT: an international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin. European/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) group.
    De Schryver EL
    Cerebrovasc Dis; 2000; 10(2):147-50. PubMed ID: 10686454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage.
    ESPRIT
    Stroke; 2003 Jun; 34(6):e45-6. PubMed ID: 12730559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergent use of anticoagulation for treatment of patients with ischemic stroke.
    Adams HP
    Stroke; 2002 Mar; 33(3):856-61. PubMed ID: 11872915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis and acute therapy of arterial embolism with special reference to cerebral embolism.
    Tettenborn B; Krämer G; Erbel R
    Herz; 1991 Dec; 16(6):444-55. PubMed ID: 1765348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
    Rost NS; Giugliano RP; Ruff CT; Murphy SA; Crompton AE; Norden AD; Silverman S; Singhal AB; Nicolau JC; SomaRaju B; Mercuri MF; Antman EM; Braunwald E;
    Stroke; 2016 Aug; 47(8):2075-82. PubMed ID: 27387994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?
    Sherman DG
    Cerebrovasc Dis; 2004; 17 Suppl 1():138-43. PubMed ID: 14694291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To Treat or Not to Treat: Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation.
    Appelros P; Farahmand B; Terént A; Åsberg S
    Stroke; 2017 Jun; 48(6):1617-1623. PubMed ID: 28487335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant treatment in stroke prevention.
    Koudstaal PJ
    Rev Neurol (Paris); 1999; 155(9):694-6. PubMed ID: 10528351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for stroke prevention in patients with atrial fibrillation.
    Howard PA
    Drugs; 1999 Dec; 58(6):997-1009. PubMed ID: 10651387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic treatments in acute ischemic stroke.
    del Zoppo GJ
    Curr Opin Hematol; 2000 Sep; 7(5):309-15. PubMed ID: 10961582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation.
    Yasaka M; Yamaguchi T
    CNS Drugs; 2001; 15(8):623-31. PubMed ID: 11524034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group.
    Lancet; 1993 Nov; 342(8882):1255-62. PubMed ID: 7901582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
    Calvet D; Bracard S; Mas JL;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.
    European Atrial Fibrillation Trial Study Group
    N Engl J Med; 1995 Jul; 333(1):5-10. PubMed ID: 7776995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.